Omega Therapeutics Inc. IPO

Omega Therapeutics is a company creating a new class of mRNA-encoded therapeutics targeted to a DNA sequence in an attempt to modify health services for patients. OMEGA, the innovative platform of epigenomic programming, is developed to coopt nature's universal biological operating system harnessing the power of epigenetics, gene control and cell differentiation. 

The IPO underwriters are
Goldman Sachs 
Jeggeries 
Piper Sandler 
Wedbush